Catalog  |  Cart  |  Log In


Promega Notes

Index by Issue

Index by Application

Subscribe

Contribute

Technical Resources
 

Publications

Promega Notes

PDF icon
Download
article
164kb

pdf?

RNasin® Ribonuclease Inhibitor Part I: Characterization of the Protein

John Shultz, Ph.D., Robin Hurst, M.S., and Natalie Betz, Ph.D.
Promega Corporation

Ribonucleases (RNases) are ubiquitous enzymes that can detrimentally affect RNA isolation in the laboratory. Many applications such as RT-PCR and in vitro transcription and translation may be affected as well. RNase can renature after autoclaving and is difficult to inactivate. Many RNase inhibitors are available commercially. Promega's RNasin® Ribonuclease Inhibitor, one of the first introduced, is exceptionally effective at controlling RNase activity during molecular biology procedures.

Subscribe!

Promega Notes 77 (2001) 8–11: Request this issue.
Index for Promega Notes 

Printed publications disclaimer.